Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Evaluate Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of OCV-S Compared to Shanchol™ in 1 to 40 Years Old Healthy Nepalese Participants

NCT04760236 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT04760236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04760236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Evaluate Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of OCV-S Compared to Shanchol™ in 1 to 40 Years Old Healthy Nepalese Participants
Lead sponsor
International Vaccine Institute
Phase
Phase 3
Overall status
Completed
Start date
October 6, 2021
Completion date
March 21, 2023
Enrollment
2,530 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cholera